methionine has been researched along with Diabetic Nephropathies in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, M; Chen, J; Dai, H; Han, F; Lin, W; Wang, J; Weng, C; Xie, X; Zhu, H | 1 |
| Chen, X; Jin, X; Wang, X; Wang, Y; Wu, L; Xing, X; Yang, W; Yang, Z; Zhang, B; Zhang, J; Zhang, X | 1 |
| Kitada, M; Koya, D; Monno, I; Ogura, Y; Xu, J | 1 |
| Beisswenger, PJ; Howell, SK; Mauer, M; Miller, ME; Rich, SS; Russell, G | 1 |
| Bàràny, P; Bergström, J; Heimbürger, O; Lindholm, B; Stenvinkel, P; Suliman, ME | 1 |
| Buraczyńska, M; Ksiazek, A; Ksiazek, P; Nowicka, T; Spasiewicz, D; Łopatyński, J | 1 |
| Guo, QH; Lu, JM; Mu, YM; Pan, CY; Sheng, CY; Yin, L; Zou, XM | 1 |
| Fowler, B; Herrmann, W; Kuhlmann, MK; Makowski, J; Obeid, R; Schorr, H | 1 |
| Coracina, A; Garibotto, G; Kiwanuka, E; Tessari, P; Valerio, A; Vedovato, M; Vettore, M; Zaramella, M | 1 |
| Chen, SY; Hsiao, PJ; Hsieh, MC; Hsin, SC; Lin, HY; Lin, KD; Lu, YC; Shin, SJ; Wang, CL | 1 |
| Bierhaus, A; Hamann, A; Nawroth, PP; Rudofsky, G; Schlotterer, A | 1 |
| Cambien, F; Hansen, BV; Nielsen, FS; Parving, HH; Poirier, O; Ricard, S; Rossing, P; Tarnow, L | 1 |
| Amiral, J; Bierhaus, A; Borcea, V; Fiehn, W; Henkels, M; Hofmann, MA; Kohl, B; Nawroth, PP; Wahl, P; Ziegler, R; Zumbach, MS | 1 |
| McLennan, SV; Turtle, JR; Yue, DK | 1 |
| Odekerken, DA; Rakic, M; Sijbrands, EJ; Silberbusch, J; Slaats, EH; Smulders, YM; Stehouwer, CD; Treskes, M | 1 |
| Chiarelli, F; Mohn, A; Morgese, G; Pomilio, M; Spagnoli, A; Tumini, S; Vanelli, M; Verrotti, A | 1 |
16 other study(ies) available for methionine and Diabetic Nephropathies
| Article | Year |
|---|---|
Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
Topics: Asparagine; Betaine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Follow-Up Studies; Humans; Isoleucine; Methionine; Prospective Studies; Valine | 2022 |
Development and assessment of diabetic nephropathy prediction model using hub genes identified by weighted correlation network analysis.
Topics: Cysteine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hormones; Humans; Methionine; Polysaccharides; Retrospective Studies | 2022 |
Methionine abrogates the renoprotective effect of a low-protein diet against diabetic kidney disease in obese rats with type 2 diabetes.
Topics: Animals; Autophagy; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, Protein-Restricted; Disease Models, Animal; Female; Kidney; Male; Mechanistic Target of Rapamycin Complex 1; Methionine; Obesity; Rats; Rats, Wistar | 2020 |
Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation.
Topics: Adolescent; Adult; Biomarkers; Child; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Glomerular Basement Membrane; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Methionine; Specimen Handling; Young Adult | 2014 |
Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
Topics: Adult; Amino Acids, Sulfur; Cardiovascular Diseases; Cross-Sectional Studies; Cysteine; Deficiency Diseases; Diabetic Nephropathies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Nutrition Assessment; Nutrition Disorders; Nutritional Status; Prevalence; Protein-Energy Malnutrition; Renal Dialysis; Serum Albumin | 2002 |
[Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes].
Topics: Adult; Alanine; Alleles; Angiotensinogen; Case-Control Studies; Cysteine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Genotype; Humans; Male; Methionine; Middle Aged; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System; Threonine | 2002 |
[The mechanism of homocysteine in Kkay mice diabetic nephropathy model].
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Homocystine; Hyperhomocysteinemia; Male; Matrix Metalloproteinase 9; Methionine; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; RNA, Messenger | 2004 |
Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.
Topics: Aged; Cystathionine; Cysteine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Folic Acid; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Male; Methionine; Methylmalonic Acid; Middle Aged; S-Adenosylhomocysteine; S-Adenosylmethionine; Transcobalamins; Vitamin B 12; Vitamin B 6 | 2005 |
Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy.
Topics: Blood Glucose; Carbon Dioxide; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fasting; Food; Glucose Clamp Technique; Glycated Hemoglobin; Heterozygote; Homocysteine; Homozygote; Humans; Insulin; Kinetics; Male; Methionine; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Sulfur | 2005 |
SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes.
Topics: Amino Acid Substitution; Codon; Diabetes Mellitus, Type 2; Diabetic Nephropathies; DNA Primers; Genetic Variation; Humans; Methionine; Polymorphism, Single Nucleotide; Small Ubiquitin-Related Modifier Proteins; Valine | 2007 |
Comment on: Lin et al. (2007) SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes: Diabetes 56: 1177-1180.
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Methionine; Mutation; Small Ubiquitin-Related Modifier Proteins | 2007 |
Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy.
Topics: Adult; Albuminuria; Angiotensinogen; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Genotype; Humans; Male; Methionine; Middle Aged; Polymorphism, Genetic; Risk Factors; Threonine | 1996 |
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Topics: Administration, Oral; Adult; Albuminuria; Case-Control Studies; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Endothelium, Vascular; Female; Homocysteine; Homocystine; Humans; Male; Methionine; Middle Aged; Reference Values; Thrombomodulin | 1997 |
Effect of glucose on matrix metalloproteinase activity in mesangial cells.
Topics: Cells, Cultured; Culture Media, Conditioned; Diabetic Nephropathies; Enzyme Activation; Extracellular Matrix; Fetus; Fibrinolysin; Fibrinolytic Agents; Glomerular Mesangium; Glucose; Humans; Metalloendopeptidases; Methionine; Phenylmercuric Acetate; Substrate Specificity; Sulfhydryl Reagents | 1998 |
Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
Topics: Administration, Oral; Adult; Aged; Albuminuria; Analysis of Variance; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Fasting; Female; Folic Acid; Homocysteine; Humans; Male; Methionine; Middle Aged; Postmenopause; Premenopause; Pyridoxal Phosphate; Regression Analysis; Risk Factors; Vitamin B 12 | 1999 |
Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy.
Topics: Adolescent; Adult; Age of Onset; Albuminuria; Child; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Fasting; Female; Homocysteine; Humans; Lipoprotein(a); Male; Methionine; Regression Analysis; Statistics, Nonparametric | 2000 |